BioCardia, Inc. Cost of Revenue
BioCardia, Inc. (BCDA) reported Cost of Revenue of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2022-03-29
- BioCardia, Inc. cost of goods and services sold for the quarter ending 2021-12-31 was $0.00.
- BioCardia, Inc. cost of goods and services sold for the quarter ending 2021-09-30 was $0.00.
- BioCardia, Inc. cost of goods and services sold for the quarter ending 2021-06-30 was $0.00.
- BioCardia, Inc. cost of goods and services sold for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- BioCardia, Inc. cost of goods and services sold for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BioCardia, Inc. cost of goods and services sold for fiscal 2020 was $4.00K, a 98.88% decline from fiscal 2019.
- BioCardia, Inc. cost of goods and services sold for fiscal 2019 was $358.00K, a 30.75% decline from fiscal 2018.
- BioCardia, Inc. cost of goods and services sold for fiscal 2018 was $517.00K, a 25.07% decline from fiscal 2017.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $0.00 derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $4.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $4.00K 10-Q · filed 2021-11-10 | $41.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $4.00K 10-Q · filed 2021-08-12 | $41.00K derived: sum of 3 quarters · filed 2021-08-12 | $65.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-13 | $41.00K derived: sum of 2 quarters · filed 2021-05-13 | $65.00K derived: sum of 3 quarters · filed 2021-05-13 | $256.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $61.00K derived: sum of 2 quarters · filed 2021-03-30 | $252.00K derived: sum of 3 quarters · filed 2021-03-30 | $358.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $24.00K 10-Q · filed 2020-11-10 | $215.00K derived: sum of 2 quarters · filed 2020-11-10 | $321.00K 10-Q · filed 2020-11-10 | $437.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $191.00K 10-Q · filed 2020-08-13 | $297.00K 10-Q · filed 2020-08-13 | $413.00K derived: sum of 3 quarters · filed 2020-08-13 | $522.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $106.00K 10-Q · filed 2020-05-15 | $222.00K derived: sum of 2 quarters · filed 2020-05-15 | $331.00K derived: sum of 3 quarters · filed 2020-05-15 | $466.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $225.00K derived: sum of 2 quarters · filed 2020-04-09 | $360.00K derived: sum of 3 quarters · filed 2020-04-09 | $517.00K 10-K · filed 2020-04-09 |
| 2018-09-30 | $109.00K 10-Q · filed 2019-11-19 | $244.00K derived: sum of 2 quarters · filed 2019-11-19 | $401.00K 10-Q · filed 2019-11-19 | $566.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-06-30 | $135.00K 10-Q · filed 2019-08-14 | $292.00K 10-Q · filed 2019-08-14 | $457.00K derived: sum of 3 quarters · filed 2020-04-09 | $604.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2018-03-31 | $157.00K 10-Q · filed 2019-05-15 | $322.00K derived: sum of 2 quarters · filed 2020-04-09 | $469.00K derived: sum of 3 quarters · filed 2020-04-09 | $672.00K derived: sum of 4 quarters · filed 2020-04-09 |
| 2017-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $312.00K derived: sum of 2 quarters · filed 2020-04-09 | $515.00K derived: sum of 3 quarters · filed 2020-04-09 | $690.00K 10-K · filed 2020-04-09 |
| 2017-09-30 | $147.00K 10-Q · filed 2018-11-08 | $350.00K derived: sum of 2 quarters · filed 2018-11-08 | $525.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $203.00K 10-Q · filed 2018-08-09 | $378.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $175.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $746.00K 10-K · filed 2019-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |